Current Paediatrics
Volume 12, Issue 4 , Pages 331-335, August 2002

New medicines for children: who is protecting the rights of the child?

Academic Division of Child Health, University Hospital, Nottingham, NG7 2UH, UK

Abstract 

Children have the right to have research undertaken on the diseases that affect them and the drugs used to treat them. They also have the right to safeguards from that research and the researchers, the right to informed consent (or their parents' consent), ‘human rights’ and the right to research governance. Sometimes, superficially, these various rights appear to be in conflict but this need not be so. This review explores the historical background to explain why there has been insufficient research into children's therapies and suggests that continuing pressure is required to rectify this anomalous situation.

Keywords: research, informed consent, human rights, research governance, drugs, trials

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence to: TS. Tel.: +44 (0)115 970 9255; Fax: +44 (0)115 970 9382E-mail: terence.stephenson@nottingham.ac.uk

PII: S0957-5839(02)90307-6

doi:10.1054/cupe.2002.0307

Current Paediatrics
Volume 12, Issue 4 , Pages 331-335, August 2002

Article Tools